39 related articles for article (PubMed ID: 8325331)
1. Solution conformation of wild-type and mutant IgG3 and IgG4 immunoglobulins using crystallohydrodynamics: possible implications for complement activation.
Lu Y; Harding SE; Michaelsen TE; Longman E; Davis KG; Ortega A; Grossmann JG; Sandlie I; García de la Torre J
Biophys J; 2007 Dec; 93(11):3733-44. PubMed ID: 17704171
[TBL] [Abstract][Full Text] [Related]
2. The Fab conformations in the solution structure of human immunoglobulin G4 (IgG4) restrict access to its Fc region: implications for functional activity.
Rayner LE; Hui GK; Gor J; Heenan RK; Dalby PA; Perkins SJ
J Biol Chem; 2014 Jul; 289(30):20740-56. PubMed ID: 24876381
[TBL] [Abstract][Full Text] [Related]
3. The hinge-engineered IgG1-IgG3 hybrid subclass IgGh
Izadi A; Karami Y; Bratanis E; Wrighton S; Khakzad H; Nyblom M; Olofsson B; Happonen L; Tang D; Sundwall M; Godzwon M; Chao Y; Toledo AG; Schmidt T; Ohlin M; Nilges M; Malmström J; Bahnan W; Shannon O; Malmström L; Nordenfelt P
Nat Commun; 2024 Apr; 15(1):3600. PubMed ID: 38678029
[TBL] [Abstract][Full Text] [Related]
4. Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3).
Plomp R; Dekkers G; Rombouts Y; Visser R; Koeleman CA; Kammeijer GS; Jansen BC; Rispens T; Hensbergen PJ; Vidarsson G; Wuhrer M
Mol Cell Proteomics; 2015 May; 14(5):1373-84. PubMed ID: 25759508
[TBL] [Abstract][Full Text] [Related]
5. Favourable interaction between heavy and light chains arrests the undesirable oligomerization of heavy chains in the refolding of denatured and reduced immunoglobulin G.
Ueda T; Maeda Y; So T; Imoto T
Cell Mol Life Sci; 1997 Dec; 53(11-12):929-34. PubMed ID: 9447245
[TBL] [Abstract][Full Text] [Related]
6. Using atomistic solution scattering modelling to elucidate the role of the Fc glycans in human IgG4.
Spiteri VA; Doutch J; Rambo RP; Bhatt JS; Gor J; Dalby PA; Perkins SJ
PLoS One; 2024; 19(4):e0300964. PubMed ID: 38557973
[TBL] [Abstract][Full Text] [Related]
7. Coming together at the hinges: Therapeutic prospects of IgG3.
Chu TH; Patz EF; Ackerman ME
MAbs; 2021; 13(1):1882028. PubMed ID: 33602056
[TBL] [Abstract][Full Text] [Related]
8. Activation of complement by an IgG molecule without a genetic hinge.
Brekke OH; Michaelsen TE; Sandin R; Sandlie I
Nature; 1993 Jun; 363(6430):628-30. PubMed ID: 8510754
[TBL] [Abstract][Full Text] [Related]
9. Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies.
Chu TH; Crowley AR; Backes I; Chang C; Tay M; Broge T; Tuyishime M; Ferrari G; Seaman MS; Richardson SI; Tomaras GD; Alter G; Leib D; Ackerman ME
PLoS Pathog; 2020 Feb; 16(2):e1008083. PubMed ID: 32092122
[TBL] [Abstract][Full Text] [Related]
10. Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia gravis in rhesus monkeys.
Losen M; Labrijn AF; van Kranen-Mastenbroek VH; Janmaat ML; Haanstra KG; Beurskens FJ; Vink T; Jonker M; 't Hart BA; Mané-Damas M; Molenaar PC; Martinez-Martinez P; van der Esch E; Schuurman J; de Baets MH; Parren PWHI
Sci Rep; 2017 Apr; 7(1):992. PubMed ID: 28428630
[TBL] [Abstract][Full Text] [Related]
11. Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis.
Rosenqvist E; Musacchio A; Aase A; Høiby EA; Namork E; Kolberg J; Wedege E; Delvig A; Dalseg R; Michaelsen TE; Tommassen J
Infect Immun; 1999 Mar; 67(3):1267-76. PubMed ID: 10024570
[TBL] [Abstract][Full Text] [Related]
12. One disulfide bond in front of the second heavy chain constant region is necessary and sufficient for effector functions of human IgG3 without a genetic hinge.
Michaelsen TE; Brekke OH; Aase A; Sandin RH; Bremnes B; Sandlie I
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9243-7. PubMed ID: 7937748
[TBL] [Abstract][Full Text] [Related]
13. The extended hinge region of IgG3 is not required for high phagocytic capacity mediated by Fc gamma receptors, but the heavy chains must be disulfide bonded.
Aase A; Sandlie I; Norderhaug L; Brekke OH; Michaelsen TE
Eur J Immunol; 1993 Jul; 23(7):1546-51. PubMed ID: 8325331
[TBL] [Abstract][Full Text] [Related]
14. Human Fc gamma RI triggering of the mononuclear phagocyte respiratory burst.
Pound JD; Lund J; Jefferis R
Mol Immunol; 1993 Apr; 30(5):469-78. PubMed ID: 8385266
[TBL] [Abstract][Full Text] [Related]
15. Human IgG isotype-specific amino acid residues affecting complement-mediated cell lysis and phagocytosis.
Brekke OH; Michaelsen TE; Aase A; Sandin RH; Sandlie I
Eur J Immunol; 1994 Oct; 24(10):2542-7. PubMed ID: 7925582
[TBL] [Abstract][Full Text] [Related]
16. Structural requirements of immunoglobulin G for binding to the Fc gamma receptors of the human tumor cell lines U937, HL-60, ML-1, and K562.
McCool D; Birshtein BK; Painter RH
J Immunol; 1985 Sep; 135(3):1975-80. PubMed ID: 3860563
[TBL] [Abstract][Full Text] [Related]
17. Functional capacity of Fc gamma receptor III (CD16) on human neutrophils.
Edberg JC; Salmon JE; Kimberly RP
Immunol Res; 1992; 11(3-4):239-51. PubMed ID: 1287118
[TBL] [Abstract][Full Text] [Related]
18. The structural requirements for complement activation by IgG: does it hinge on the hinge?
Brekke OH; Michaelsen TE; Sandlie I
Immunol Today; 1995 Feb; 16(2):85-90. PubMed ID: 7888072
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
